Thorough QT/QTc Study of Staccato Loxapine for Inhalation in Healthy Volunteers.

Trial Profile

Thorough QT/QTc Study of Staccato Loxapine for Inhalation in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Loxapine; Moxifloxacin
  • Indications Acute bronchitis; Acute exacerbations of chronic bronchitis; Bacterial infections; Bipolar disorders; Community-acquired pneumonia; Intra-abdominal infections; Migraine; Pelvic inflammatory disorders; Respiratory tract infections; Schizophrenia; Skin and soft tissue infections; Tuberculosis
  • Focus Adverse reactions
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 27 May 2010 Results of this and another phase I loxapine safety trial (700028292) will be presented at the 163rd Annual Scientific Sessions of the American Psychiatric Association, according to an Alexza Pharmaceuticals media release.
    • 26 May 2010 Results presented at the 163rd Annual Meeting of the American Psychiatric Association.
    • 23 Jun 2009 Actual patient number (46) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top